Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kuhlmann Shirley R.
EVP and General Counsel at COLLEGIUM PHARMACEUTICAL. Filing since 15 Oct 2020.
CIK 0001734919
Company
Date
Role
Action
Shares
Amount
Of holding
COLL
COLLEGIUM PHARMACEUTICAL, INC
6 Mar 2025
EVP and General Counsel
Sold at will
26,067
$742.95K
19.4%
COLL
COLLEGIUM PHARMACEUTICAL, INC
5 Mar 2025
EVP and General Counsel
Sold at will
20,000
$560.53K
13.0%
COLL
COLLEGIUM PHARMACEUTICAL, INC
4 Mar 2025
EVP and General Counsel
Sold at will
40,000
$1.12M
20.6%
COLL
COLLEGIUM PHARMACEUTICAL, INC
10 Jan 2025
EVP and General Counsel
Sold on a plan
27,500
$908.63K
18.7%
COLL
COLLEGIUM PHARMACEUTICAL, INC
6 Sep 2024
EVP and General Counsel
Sold at will
977
$36.59K
0.8%
COLL
COLLEGIUM PHARMACEUTICAL, INC
5 Sep 2024
EVP and General Counsel
Sold at will
19,248
$737.20K
13.8%
COLL
COLLEGIUM PHARMACEUTICAL, INC
3 Jun 2024
EVP and General Counsel
Sold on a plan
25,000
$814.18K
15.2%
COLL
COLLEGIUM PHARMACEUTICAL, INC
27 Nov 2023
EVP and General Counsel
Sold on a plan
25,600
$660.01K
17.6%
COLL
COLLEGIUM PHARMACEUTICAL, INC
26 Jun 2023
EVP and General Counsel
Sold on a plan
17,984
$390.63K
13.1%
COLL
COLLEGIUM PHARMACEUTICAL, INC
13 Feb 2023
EVP and General Counsel
Sold, plan not stated
21,811
$586.28K
13.7%
COLL
COLLEGIUM PHARMACEUTICAL, INC
15 Sep 2022
EVP and General Counsel
Sold, plan not stated
38,589
$697.30K
26.1%
COLL
COLLEGIUM PHARMACEUTICAL, INC
11 Aug 2022
EVP and General Counsel
Sold, plan not stated
300
$6.00K
0.2%
COLL
COLLEGIUM PHARMACEUTICAL, INC
10 May 2021
EVP and General Counsel
Sold, plan not stated
7,000
$159.39K
7.2%
COLL
COLLEGIUM PHARMACEUTICAL, INC
20 Jan 2021
EVP and General Counsel
Sold, plan not stated
6,081
$148.68K
5.5%
COLL
COLLEGIUM PHARMACEUTICAL, INC
15 Oct 2020
EVP and General Counsel
Sold, plan not stated
7,060
$146.99K
10.9%
15 decisions on file.
